Page last updated: 2024-08-24

glucose, (beta-d)-isomer and rolipram

glucose, (beta-d)-isomer has been researched along with rolipram in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (77.78)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Turner, NC; Wood, LJ1
Carlson, RP; Hartman, DA; Ochalski, SJ1
Harris, HJ; Klemm, P; Perretti, M1
Hellewell, PG; Miotla, JM; Teixeira, MM1
Kidao, S; Merricks, EP; Pryzwansky, KB1
Au, BT; Collins, PD; Teixeira, MM; Williams, TJ1
Boichot, E; Escofier, N; Germain, N; Lagente, V; Martins, MA; Silva, PM1
Cortijo, J; Dasí, FJ; Morcillo, EJ; Ortiz, JL1
Cesari, N; Dal Piaz, V; Di Giannuario, A; Dominici, L; Pieretti, S1

Other Studies

9 other study(ies) available for glucose, (beta-d)-isomer and rolipram

ArticleYear
Superoxide generation by guinea-pig peritoneal macrophages is inhibited by rolipram, staurosporine and mepacrine in an agonist-dependent manner.
    Cellular signalling, 1994, Volume: 6, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alkaloids; Animals; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Guinea Pigs; Macrophages, Peritoneal; Male; N-Formylmethionine Leucyl-Phenylalanine; Phospholipases A; Phospholipases A2; Phosphoric Diester Hydrolases; Platelet Activating Factor; Protein Kinase C; Pyrrolidinones; Quinacrine; Respiratory Burst; Rolipram; Staurosporine; Superoxides; Tetradecanoylphorbol Acetate; Zymosan

1994
The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A.
    Inflammation research : official journal of the European Histamine Research Society ... [et al.], 1995, Volume: 44, Issue:7

    Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cytokines; Dexamethasone; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Humans; Imidazoles; Interleukin-1; Interleukin-6; Interleukin-8; Leukocytes; Lipopolysaccharides; Lipoxygenase Inhibitors; Male; Phosphodiesterase Inhibitors; Pyrrolidinones; Regression Analysis; Rolipram; Thiazoles; Tumor Necrosis Factor-alpha; Zymosan

1995
Effect of rolipram in a murine model of acute inflammation: comparison with the corticoid dexamethasone.
    European journal of pharmacology, 1995, Jul-25, Volume: 281, Issue:1

    Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Interleukin-1; Leukocyte Elastase; Leukocytes; Male; Mice; Pancreatic Elastase; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Time Factors; Tumor Necrosis Factor-alpha; Zymosan

1995
Suppression of acute lung injury in mice by an inhibitor of phosphodiesterase type 4.
    American journal of respiratory cell and molecular biology, 1998, Volume: 18, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Capillary Permeability; Cyclic Nucleotide Phosphodiesterases, Type 4; Disease Models, Animal; Female; Humans; Infant, Newborn; Lipopolysaccharides; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Circulation; Pyrrolidinones; Respiratory Distress Syndrome; Rolipram; Time Factors; Tumor Necrosis Factor-alpha; Zymosan

1998
Compartmentalization of PDE-4 and cAMP-dependent protein kinase in neutrophils and macrophages during phagocytosis.
    Cell biochemistry and biophysics, 1998, Volume: 28, Issue:2-3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cell Adhesion; Cell Compartmentation; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytochalasin D; Humans; Isoenzymes; Macrophages; Neutrophils; Nucleic Acid Synthesis Inhibitors; Peroxidase; Phagocytosis; Phagosomes; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Signal Transduction; Zymosan

1998
Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol.
    British journal of pharmacology, 1998, Volume: 123, Issue:6

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adult; Albuterol; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Drug Synergism; Humans; Interleukin-8; Neutrophils; Nitriles; Phosphodiesterase Inhibitors; Prostaglandins; Pyridines; Pyrrolidinones; Rolipram; Zymosan

1998
Effects of interleukin-10 and modulators of cyclic AMP formation on endotoxin-induced inflammation in rat lung.
    Fundamental & clinical pharmacology, 1999, Volume: 13, Issue:1

    Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Animals; Bronchoalveolar Lavage Fluid; Bucladesine; Cell Count; Cyclic AMP; Dose-Response Relationship, Drug; Endotoxins; Free Radical Scavengers; Inflammation; Interleukin-10; Lipopolysaccharides; Luminescent Measurements; Luminol; Lung; Male; Neutrophils; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Wistar; Rolipram; Salmeterol Xinafoate; Superoxide Dismutase; Theophylline; Tumor Necrosis Factor-alpha; Zymosan

1999
beta-Adrenoceptor stimulation up-regulates phosphodiesterase 4 activity and reduces prostaglandin E2-inhibitory effects in human neutrophils.
    Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:4

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic Agonists; Adult; Albuterol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Dinoprostone; Enzyme Inhibitors; Humans; In Vitro Techniques; Neutrophil Activation; Neutrophils; Receptors, Adrenergic, beta-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rolipram; Superoxides; Up-Regulation; Zymosan

2000
Local anti-inflammatory effect and behavioral studies on new PDE4 inhibitors.
    Life sciences, 2006, Jul-17, Volume: 79, Issue:8

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Inflammatory Agents; Cyclic Nucleotide Phosphodiesterases, Type 4; Edema; Male; Mice; Motor Activity; Pain Measurement; Pain Threshold; Phosphodiesterase Inhibitors; Pyridazines; Rolipram; Zymosan

2006